MAnagement of Patients With Pancreatic Cysts Using Integrated Molecular PathologyGASTROINTESTINAL ENDOSCOPYIF7.52015-05-011PREAI
Integrated molecular pathology accurately determines the malignant potential of pancreatic cystsENDOSCOPYIF12.82014-10-1454OAAI
Clinical Utility of Integrated Molecular Pathology (IMP) in Determining the Malignant Potential of Pancreatic CystsAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62014-10-010PRE
Clinical Validity of Integrated Molecular Profiling in Diagnosing Pancreatic Lesions: Interim Results (N=422) of an Outcomes-based RegistryAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62013-10-010PRE
The Performance of Second-line Integrated Molecular Profiling Compared to Common, First-line Testing Risk Features in Diagnosing and Predicting Benign and Malignant Pancreatic Lesions: Interim Results from an Outcome-based Registry in 422 PatientsAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62013-10-010PRE
Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humansNEUROGASTROENTEROLOGY AND MOTILITYIF2.92010-11-0977PREAI
The learning curve for EUS-guided FNA of pancreatic cancerGASTROINTESTINAL ENDOSCOPYIF7.52004-01-01136PREAI
Amitriptyline reduces activation of the anterior cingulate cortex in irritable bowel syndrome patients during rectal painGASTROENTEROLOGYIF25.12003-04-016OA
Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distentionGASTROENTEROLOGYIF25.12000-05-01487OA
Functional MRI measurement of brain activity during rectal distension in normal volunteers and patients with irritable bowel syndrome.GASTROENTEROLOGYIF25.11998-04-011OAAI
Effect of amitryptiline on symptoms, sleep, and visceral perception in patients with functional dyspepsiaAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.61998-02-01179PREAI